ChemicalBook > CAS DataBase List > Linagliptin Impurity F

Linagliptin Impurity F

Product Name
Linagliptin Impurity F
CAS No.
1673546-62-7
Chemical Name
Linagliptin Impurity F
Synonyms
Linagliptin-6;LIGLIPTIN IMPURITY Q;Linagliptin impurity 03;(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl;(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroace;(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide;Acetamide, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-2,2,2-trifluoro-;Linagliptin Impurity QQ: What is Linagliptin Impurity Q Q: What is the CAS Number of Linagliptin Impurity Q Q: What is the storage condition of Linagliptin Impurity Q;(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity);Linagliptin impurity 5/(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
CBNumber
CB13034786
Molecular Formula
C27H27F3N8O3
Formula Weight
568.55
MOL File
1673546-62-7.mol
More
Less

Linagliptin Impurity F Property

Density 
1.46±0.1 g/cm3(Predicted)
pka
10.63±0.20(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H312Harmful in contact with skin

H315Causes skin irritation

H319Causes serious eye irritation

H332Harmful if inhaled

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P322Specific measures (see …on this label).

P330Rinse mouth.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P363Wash contaminated clothing before reuse.

P501Dispose of contents/container to..…

More
Less

Linagliptin Impurity F Chemical Properties,Usage,Production

Uses

3-Trifluoroacetylamino Linagliptin is a derivative of Linagliptin , which is a DPP-??4 (dipeptidyl peptidase-??4) inhibitor used in the treatment of type 2 diabetes.

Linagliptin Impurity F Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Linagliptin Impurity F Suppliers

Novachemistry
Tel
44-20819178-90 02081917890
Fax
(0)2080432064
Email
info@novachemistry.com
Country
United Kingdom
ProdList
4381
Advantage
58
More
Less

View Lastest Price from Linagliptin Impurity F manufacturers

Hangzhou Huarong Pharm Co., Ltd.
Product
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroace 1673546-62-7
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
99%
Supply Ability
10KG
Release date
2021-09-17

1673546-62-7, Linagliptin Impurity FRelated Search:


  • Linagliptin impurity 5/(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
  • (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl
  • Linagliptin-6
  • (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
  • Acetamide, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-2,2,2-trifluoro-
  • (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroace
  • (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity)
  • Linagliptin Impurity QQ: What is Linagliptin Impurity Q Q: What is the CAS Number of Linagliptin Impurity Q Q: What is the storage condition of Linagliptin Impurity Q
  • Linagliptin impurity 03
  • LIGLIPTIN IMPURITY Q
  • 1673546-62-7
  • C27H27F3N8O3